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Abstract
Toll-Like Receptors (TLR) are critical elements of the innate arm of the vertebrate immune system. They constitute a
multigenic family of receptors which collectively bind a diverse array of – exogeneous as well as endogeneous – ligands. An
exponential burst of knowledge has defined their biological role in fight against infections and generation/modulation of
auto-immune disorders. Hence, they could at least be conceptually recognized – despite being structurally unrelated – as
innate counterparts to Major Histocompatibility Complex (MHC) molecules – equally recognizing antigenic ligands (albeit
structurally more homogeneous i.e., peptides), again derived from self and/or non-self sources – preeminent this time in
adaptive immunity. Our great disparities in face of infections and/or susceptibility to auto-immune diseases have provoked
an intense search for genetic explanations, in part satisfied by the extraordinary MHC allelic repertoire. An equally in-depth
and systematic analysis of TLR diversity is lacking despite numerous independent reports of a growing number of SNPs
within these loci. The work described here aims at providing a preliminary picture of the allelic repertoire – and not purely
SNPs – of all 10 human TLR coding sequences (with exception of TLR3) within a single cohort of up to 100 individuals. It
appears from our work that TLR are unequally polymorphic: TLR2 (DNA alleles: 7/protein alleles: 3), 4 (4/3), 7 (6/3), 8 (9/2)
and 9 (8/3) being comparatively least diverse whereas TLR1 (11/10), 5 (14/12), 6 (10/8) and 10 (15/10) show a substantial
number of alleles. In addition to allelic assignment of a large number of SNPs, 10 new polymorphic positions were hereby
identified. Hence this work depicts a first overview of the diversity of almost all human TLR genes, a prelude for large-scale
population genetics as well as genetic association studies.
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Introduction
In collaboration with other pattern recognition Receptors, Toll-
like Receptors (TLRs) govern the innate arm of the immune
system. The first member of this family, TOLL, was originally
described through its function in the Drosophila embryonic
development and was later found to be involved in the response
against Gram positive bacteria and fungi within this organism [1].
This discovery prompted the in silico identification of mammalian
orthologues. A positional cloning approach of the Lps
d locus led to
the identification of the mouse TLR4 and to its description as the
LPS sensor which is essential for an efficient response against
Gram-negative bacteria [2]. These findings emphasized the
evolutionary conservation of the TLRs and suggested that these
molecules play a fundamental role in the early detection of
pathogens and the appropriate subsequent innate immune
response (reviewed in [3,4]).
To date, 10 TLRs have been described in humans (12 in mice)
dispersed all over the genome. The molecular identification of their
respective ligands, which has been unraveled in most cases,
revealed that TLRs allow detection of virtually any potential
pathogen and a number of self-entities. As such, they constitute an
‘‘innate early repertoire’’, whose importance is confirmed by the
increasing amount of micro-organisms that are sensed by the TLR
system, as evidenced by the susceptibility phenotypes observed
when TLR-deficient animals are challenged by various pathogens.
The molecular diversity of the motifs recognized by the different
TLRs is an intriguing feature (discussed in [5]). Despite structural
homogeneity (defined by the presence of extracellular leucine-rich
repeats, a transmembrane domain and a Toll-Interleukine 1
Receptor - TIR - region), TLRs are able to sense the presence of
unrelated molecules such as triacetylated lipopeptides (TLR1/2),
lipotechoic acid (TLR2/6), double-stranded RNA (TLR3), lipo-
ploysaccharide (TLR4), flagellin (TLR5), single-stranded RNA
(TLR7) or unmethylated double-stranded DNA (TLR9) to cite only
a few ligands (reviewed in [6]). Heterodimerization between TLRs
or association with co-receptors such as CD14 or CD36 clearly
contributes to increasing the diversity of molecules that can be
recognized by TLRs [7,8]. However, this wide variety of ligands
makes the TLRs a critical interface between invading pathogens
and the host. In addition, the recent discovery that TLR signaling
has a profound impact on the activation and shaping of the
adaptive immune response has highlighted the importance of this
field and explains its recent explosive development.
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7803In humans, challenging questions regarding the role of TLRs
in the defense against infectious diseases are complicated by
environmental factors and multiple genetic differences between
people. However, several studies have evidenced the association of
specific polymorphisms in genes encoding TLRs and microbial
infections. One of the well-described examples is the presence of
D299G and T399I substitutions in TLR4 which causes decreased
airway response to inhaled lipoloysaccharide in humans [9]. Since
then, a large collection of reports has studied the association of
these TLR4 SNPs with infectious diseases (reviewed in [10] with
conflicting conclusions [11]. Additional analysis of patients
suffering from meningococcal infections established that rare
mutations affecting TLR4 structure contribute to disease suscep-
tibility [12]. Association of human diseases with polymorphisms in
other TLRs have been investigated, including TLR2 [13], TLR3
[14] and TLR 5 [15]. TLR9, which classically senses DNA
bearing unmethylated CpG motifs of bacterial or viral origins, also
activates signaling when stimulated with mammalian DNA
engaged within immune complexes [16]. This has led to the
hypothesis that TLR9 might be implicated as risk factors in the
development of autoimmune diseases such as systemic lupus
erythematosus (SLE). Altogether, these studies have provided
substantial evidence for an association between the presence of
some SNPs in TLRs and the prevalence of infectious diseases.
However, strong genetic association has never been achieved,
mostly because the correlations were measured in small popula-
tions. To confirm the impact of TLRs in human health, more
epidemiological studies and additional genomic analysis need to be
performed. However prior to embarking in such vast investigations
a clear picture of the allelic (and importantly not only SNP)
repertoire of all TLR is needed. This is reminiscent somewhat to
the situation with histocompatibility genes, which could concep-
tually (and only conceptually) be considered adaptive equivalents
to the TLR or vice versa. The HLA genes are indeed highly
polymorphic [17]. This polymorphism both serves as a primary
tool for a population-wide protection against infectious agents and
is involved in graft rejection and the still partly mysterious
susceptibility to a large number of diseases. This study aims to
contribute to bringing the TLRs ‘‘up-to-speed’’ with HLA genes.
Results
TLR1
TLR1, when associated to TLR2 (see below) in a heterodimeric
complex, is able to sense triacylated lipoproteins purified from
mycobacteria or synthetic peptides such as N-palmitoyl-S-dipalmi-
toylglyceryl (Pam3) Cys-Ser-(Lys)4 (CSK4) [18]. To date, few
pathologies have been genetically associated to TLR2 variants; an
increased risk to develop prostate cancer has been traced to TLR1
(and TLR6 and 10 which are located on the same chromosomal
locus,[19]and morerecently,resistanceto leprosywas linkedto the
frequent I602S TLR1 allele [20]. A search for TLR1 SNPs in
several databases (http://snpper.chip.org/bio/ and http://www.
ncbi.nlm.nih.gov/SNP/) identified 13 mutations at positions
leading to a non-synonymous amino-acid change. As illustrated
inFig.1,our sequencingeffort performedon94 individualsallowed
Figure 1. Schematic representation of TLR1 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Non
Synonymous (NS) SNPs are indicated in bold letters and those in grey boxes represent new NS-SNPs identified in this study. Leucine-Rich Repeats
(LRR) are represented by grey boxes (dark grey for the C-terminus LRR). The trans-membrane (TM) domain is shown as a hatched box and the Toll-
Interleukin 1 Receptor (TIR) domain as a dotted hexagon. The position of NS-SNPs recorded in databases but not identified in this study is indicated.
doi:10.1371/journal.pone.0007803.g001
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characterize four additional mutations leading to a different amino-
acid sequence of the TLR1 protein. According to the recently
published crystallographic model of TLR1/2 bound to the
PAM3CSK4 [21], L443I, V542A and T565S are located at the
interface important for dimer formation. Therefore, such alter-
ations which have the potential to impair not only TLR1/2, but
also TLR1/10 association, could have a wider than suspected
impact on immune defense. On the other hand, I57M mutation,
localized at the N terminus of the TLR1 protein, could potentially
affect the folding of the extracellular domain and thus, modify
ligand recognition. These 4 SNPs were detected in 1 to 2% of the
samples (N=93 genomic DNAs tested for TLR1) and each of them
define a new allele (see Table S1) which was observed at a low
frequency (0.56% of the population among the 11 TLR1 alleles
which have been defined in this study). This allelotyping analysis
also shows that the frequent I602S allele, which has been mostly
studied so far, is usually associated with the S248N mutation and in
7.8% of the population, is also linked to the R80T SNP.
TLR2
Despite its reported association with TLR1, TLR2 variants are
associated to a much wider panel of infectious diseases. These can
be of viral [22,23] or bacterial [24,25] origin. Currently, 24
polymorphisms within the human TLR2 gene are described,
among which 13 are non-synonymous mutations leading to amino
acid exchanges. We were able here to identify 2 already known
SNPs affecting the TLR2 protein sequence (P681H and R753Q)
in addition to 4 synonymous SNPs (Fig. 2). No novel SNP could be
identified in the course of our sequencing of 42 samples. These 6
nucleotides changes served to define 7 alleles, but only 3 forms of
the TLR2 protein (Table S2), those expressing P631H and R753Q
representing respectively 2.33 and 3.49% of our population.
TLR4
Among TLRs, TLR4 appears to have been the subject of
intense attention. 28 non synonymous (and 7 synonymous)
positions have been described so far, among which two co-
segregating mutations inducing D299G and T399I amino acid
change have been studied with remarkable scrutiny (Fig. 3). A
large body of genetic analysis suggests potential association
between the presence of these frequent SNPs and several
pathologic conditions of diverse etiology. Because of its role as a
component (in addition to MD2 and CD14) of the LPS receptor,
TLR4 polymorphisms were mostly involved in susceptibility to
Gram-negative bacteria infections. However, increased fungal or
viral infections and non-infectious conditions such as atheroscle-
rosis were also tentatively linked to the presence of the most
frequent D299G and T399I SNPs [10,26]. In several cases,
however, genetic association remains controversial [11] and in
some cases, increased resistance was observed in human carrying
these variants [27]. Our sequence survey of 49 individuals
confirms co-segregation of the high frequency D299G and
T399I SNPs whose presence identifies our allele 1 in 5.1% of
the cases (Table S3). Furthermore, we have identified an
additional rare (1% among the alleles identified here) amino acid
change (C281Y) in the TLR4 ectodomain. This variant, which
was not detected in previous sequencing surveys of large cohorts
[28,29], was later identified in an exhaustive study of TLR4
variations in meningococcal sepsis patients compared to ethnic
Figure2.Schematic representationof TLR2 and positionand frequencyof SingleNucleotide Polymorphisms(SNPs). LegendissimilartoFig.1.
doi:10.1371/journal.pone.0007803.g002
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occurrence of common variants nor rare single SNPs were
significantly associated with increased risk of disease. However, it
was observed that, collectively, rare TLR4 variants were
overrepresented in the patient population.
TLR5
TLR5 responds to bacterial flagellin [30]. Our analysis of the
TLR5 coding sequences in 97 unrelated individuals shows that we
detected 9 non synonymous SNPs out of 21 recorded in the
databases, including the frequent R392Stop, N592S and F616L
(Fig. 4). In addition, we found 3 additional non-synonymous SNPs
in the TLR5 ectodomain, two of which (S353G and M484I) are
located within Leucine-rich repeats (LRR) and the fourth (S247T)
outside of these domains. Altogether, the 15 TLR5 SNPs that we
detected in our cohort were grouped in 14 alleles whose translation
generates 12 forms of the TLR5 protein (Table S4) among which
those containing the new non-synonymous changes alone occur at
low frequency (,1%). We also note that Q181K either segregates
with both R392Stop (Allele 6, 4.2%) or with F616L (Allele 5 at a
frequency of 0.5%).
TLR6
As mentioned above, TLR6 interaction with TLR2 has been
reported to be required for recognition of microbial determinants
such as zymosan and Lipoteichoic acid (LTA) [31,32]. In this
study, we have detected 6 non-synonymous SNPs out of 21 which
are already known and deposited in databanks. One new
polymorphic position inducing an amino acid change was also
observed (Fig. 5): P740L is located inside the TIR domain and
thus, could modify signal transduction. The TLR6 allelic
repertoire, derived from sequences obtained from 96 unrelated
donors is shown on Table S5. 10 alleles have been identified here
at the nucleotide level, among which allele 6 expressing the P740L
SNP is represented in 1.1% (denominated allele 4 when alleles are
defined according to amino acids sequences) of TLR6 proteins in
our population.
TLR7 and TLR8
These receptors are believed to bind viral and synthetic single-
stranded RNAs as well as Imidazoquinoline-based small molecules
and guanosine-based nucleosides [33,34,35]. This functional
similarity is correlated to the high sequence homology between
Figure 3. Schematic representation of TLR4 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Legend is similar
to Fig. 1.
doi:10.1371/journal.pone.0007803.g003
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and TLR8, but also TLR3 and TLR9 are expressed at the
endosomal membrane). Our analysis of TLR7 sequences in 51
individuals did not allow the identification of additional SNPs to
those already recorded in databanks. As seen on Fig. 6, we
detected 5 SNPs among which 2 are non-synonymous (Q11L and
A448V). Allelic variants analysis (Table S6) indicates that Q11L is
frequently represented in TLR7 mutant alleles (alleles 2 and 3,
17.5% combined) and in 2.5%, is associated to A448V mutation
(allele 2). Comparatively, TLR8 shows very limited variation. Out
of 15 reported SNPs, only 3 (which were not identified in this
study) induce amino acid variation in the protein sequence.
However, we have identified an additional non-synonymous SNP
(D428N, see Fig. 7) which was observed in 2% of the DNA tested.
This mutation induces the replacement of a negatively charged
residue by a basic one and occurs in a Leucine-rich repeat (LRR),
which may prompt further investigation (see discussion) given its
location at the probable dimer interface (according to other TLRs
crystallographic data). Allele classification (Table S7) shows that
this modification segregates with additional SNPs which do not
generate differences at the protein level (allele 7, 1% of the
chromosomes). At the protein level, D428N identifies allele 2.
TLR9
The discovery of unmethylated (prokaryotic) DNA as the ligand
for TLR9 [36] has fuelled several hypotheses regarding the
likely involvement of this receptor in innate immune defence. Few
genetic association studies have evaluated the linkage between
TLR9 SNPs and infectious diseases. Recently, rapid progression
phenotype following HIV infection [37] and malaria manifestation
during pregnancy [38] were both traced to TLR9 polymorphic
positions. It was also suggested that the function of TLR9 in B
cell response to autoantigens and in dendritic cell response to
chromatin immune complexes may have an effect on susceptibility
to SLE. Yet, a recent evaluation of this possibility provided negative
results [39]. So far, the most studied TLR9 SNP (C-1237T), which
has been linked to asthma [40], is located within the promoter
region of the TLR9 gene. It is therefore surprising to note that
among the 16 non-synonymous SNPs in the TLR9 coding sequence
and recorded in public databases(seeFig. 8),none hasbeenassessed
so far in relation to any pathology. Our TLR9 sequencing survey in
93 donors has led to the discovery of an additional non-synonymous
SNP inducing a modification in a LRR located in the central part of
the ectodomain (R311Q) which, by its sole presence, define a
specific allele (allele 3 in Table S8). According to the location of the
mutation and byanalogy with published TLRstructures [21,41,42],
this TLR9 allele might exhibit defects in dimer formation and/or
ligand recognition.Translation of the different nucleotide sequences
predicts 3 TLR9 proteins, among which each mutated form
(allele 2, R863Q and allele 3, R311Q) represents 0.5%.
TLR10
TLR10 is the last Toll-like Receptor discovered in man [43] and
since then, it has remained an orphan member of this family.
TLR10 shares with TLR1 and TLR6 a common locus on
chromosome 4p14 and the three TLRs are structurally similar to
Figure 4. Schematic representation of TLR5 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Legend is similar
to Fig. 1.
doi:10.1371/journal.pone.0007803.g004
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most SNPs and suggested possible association of this gene with
asthma [44]. In this study, TLR10 was sequenced for 50 donors.
As illustrated Fig. 9, we identified most polymorphic positions in
the coding sequence (18 out of a total of 29 which are reported)
among which 9 SNPs induce amino acid change. We have also
detected one new non-synonymous SNP (L59I) in the second LRR
of the ectodomain. Table S9 lists the 15 TLR10 alleles, among
which allele 9 expressing the single L59I mutation represents
1.32% of the repertoire.
Discussion
Susceptibility to infections is heritable, as demonstrated in a
seminal study which examined and compared the cause of death
among adoptees to that of their biological or adoptive parents [45].
Although many immunodeficiencies have been mapped to a single
locus (monogenic diseases, such as X-linked or autosomal severe
combined immunodeficiencies), until recently, a role for TLR in
susceptibility to infections had not firmly been assessed. Two genetic
studies have demonstrated the involvement of downstream compo-
nentsusedbytheTLRpathway:IRAK4mutationshavebeenlinked
to increased infections by pyogenic bacteria [46] and UNC-96B
defects in two children was associated to HSV-1 encephalitis [47].
The samegroup hasnowidentified a TLR3mutation inhumansand
reports for the first time HSV-1 encephalitis in children carrying the
mutated allele [48]. This contrasts with the wealth of information
which was produced with animal models in which experimental
infections in mice have been instrumental in defining the TLR
specificities. Despite high homologies between mouse and human
genes, it is now clear that human genetic diversity (as opposed to
genetic homogeneity in mouse models) and environmental condi-
tions which may or may not bring in close proximity a pathogen and
its host, render human genetic studies, in addition to the develop-
ment of animal models, a required step to understand immune
responses to natural infections. To contribute to this goal, we have
resequenced TLR1–10 (but not TLR3 which was excluded from the
analysis for technical reasons, see Materials and Methods) in up to
one hundred unrelated individuals of Caucasian origin, and
‘‘scanned’’ all the synonymous and non-synonymous SNPs in the
coding sequence. Because we focused our study to the coding
sequences of TLRs, we concentrated our present analysis on non-
synonymous SNPs, which can introduce modifications potentially
affectingthefunctionofthecorrespondingproteins.Nevertheless,we
also recorded synonymous SNPs and compared them to those which
are already described in public databases. From this effort, several
points deserve to be highlighted. (i) First, the general picture
emerging from the comparison of TLR1–10 allelic repertoire is that
these molecules are not equally polymorphic. Clearly, TLR10, 5, 1
and 6 show the highest level of variation in our Caucasian sample
Figure 5. Schematic representation of TLR6 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Legend is similar
to Fig. 1.
doi:10.1371/journal.pone.0007803.g005
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proteins. Only 3 non-synonymous SNPs we detected for TLR4,
whereas29aredepositedindatabanks.Thelimitednumberofalleles
identified in our study likely reflects the lowest amount of samples
which were analysed, compared to more extensive investigations
[28,29]. On the contrary, besides this sub-group of highly variable
TLRs, TLR 7, 8 and 9 appear less flexible. We detected only two
known non-synonymous SNPs in TLR7 (out of 12 which are
recorded), one in TLR8 (in addition to 3 known non-synonymous
SNPs) and two in the TLR9 coding sequence (out of 16 already
described). We speculate that selection pressure prevents mutations
in these genes because the proteins encoded by these TLRs
recognize nucleic-acid-based structures which are highly conserved
and subjected to almost no possible variation in their size, charge or
other physicochemical features. Conversely, evolutionary constrains
have likely shaped TLR1, 4, 5 and 6 to render them able to detect a
whole panel of pathogens, despite expression of highly variable
molecules such as LPS and lipoproteins among different microor-
ganisms. In this regard, TLR2 limited variation remains enigmatic,
but the multiple alleles of the still orphan TLR10 suggests that this
molecule, possibly associated with TLR1 or TLR2, likely partici-
pates in bacterial determinants sensing. (ii) Second, several new non-
synonymous polymorphic positions were identified in this study
(I57M, L443I, V542A and T565S in TLR1, S247T, S353G and
M484I for TLR5; D428N in TLR8; R311Q in TLR9 and L59I in
TLR10). All these positions are located in the ectodomain of the
TLRs which contains the LRR and could therefore potentially affect
ligand binding and/or dimer formation. Future studies, using TLR
expression vectorstransfectedinculture cells,should clarifytheeffect
of these mutations on the functionality of these receptors. In this
respect, it is interesting to note that such studies designed to quantify
the impact of specific SNPs in TLRs have been performed only in
few instances [24]. (iii) Third, our effort, combined with those of
others, is important to obtain reliable sequence and SNP
information, which ultimately, are validated by comparing data
from multiple sources. For instance, we observed that the so-called
S248N variant of TLR1 is present in 3 alleles (alleles 5, 6 and 7;
Table S1) with a combined frequency of 70.24%. In agreement with
others [49], our data indicate that Asn (N) residue at position 248
rather represents the normal form of TLR1 and its replacement by a
Ser(S)identifiesa variantform. (iv)Lastly,we wishtoemphasizethat
our effort provided not only frequencies for individual SNPs in the
TLR coding sequences, but also afforded an overall picture of the
allelic repertoire for this important class of proteins. Resequencing is
a useful approach to assemble SNPs at the level of a single gene and,
as pointed by others [50,51], is more powerful than single SNP
analysis to analyse complex traits. Because recombination between
SNPsmay affectgene variability, ourdescription ofall the alleles ina
single cohort provides valuable information regarding the heteroge-
neityofTLR genesinan ethnically-definedpopulation. It should also
contributetoclarifytheeffectofsingleSNPsinTLRswhichwerenot
convincingly replicated in several independent investigations (see
[52] for a recent update on TLR polymorphisms linked to human
disease).
Figure 6. Schematic representation of TLR7 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Legend is similar
to Fig. 1.
doi:10.1371/journal.pone.0007803.g006
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combination in rare alleles) may play a decisive role in common
diseases, knowledge of allelic repertoire of genes involved in
immune responses is an essential step toward the understanding of
the genetic grounds of infectious or auto-immune pathologies. The
impressive diversity of MHC-related genes provided essential clues
to this problem, but the re-evaluated importance of innate
immunity in the defence against pathogens has recently stimulated
investigations designed to thoroughly describe pattern recognition
receptors (PRR) such as TLRs at the genetic level in humans.
Altogether, our data, which improve the picture of TLR diversity
in humans, contribute to this endeavour. As such, they provide
preliminary foundation for a future effective genetic analysis
enabling their inclusion in ‘‘personalized’’ or ‘‘individualized’’
predictive medicine as related to the immune function.
Materials and Methods
Origin of genomic DNA
DNA samples arise from 100 anonymous Caucasian blood
donors from the Strasbourg, France area, in accordance with the
actual French legislation at the time of collection.
PCR amplification, cloning and sequencing
In most cases, PCR reactions were performed using the Expand
Long Template PCR system (Roche Diagnostics) using 400 ng of
genomic DNA according to the manufacturer’s specifications
except for the annealing temperature and in some cases for the
number of cycles (Table S10). For TLR4, shorter exons were
individually amplified using standard Taq DNA Polymerase
(Promega, WI, USA) using 200 ng of genomic DNA. All primers
were designed by aligning cDNA sequences with genomic
(chromosomal) sequences available in public databases (NCBI
and Ensembl). The PCR products were purified using the
NucleospinH extract purification kit (Macherey-Nagel) and
sequenced using ABI PRISM BigDye terminator v3.0 Cycle
Sequencing Ready Reaction KitH with AmpliTaq DNA Polymer-
ase, FS (Applied Biosystems Warrington, UK). Sequencing
primers were designed in order to cover an average of 450 bp.
Reactions were performed using 2 ml of Sequencing mix, 6.4 pmol
of primers, 150–200 ng of PCR products in a total volume of
10 ml. The reactions were run on an ABI 3100 DNA Sequencing
System and analyzed using Applied Biosystem’s SeqScapeH
software using published sequences as reference. Using several
combinations of primer pairs, we could not successfully amplify the
totality of TLR3, neither using long-range technology, we equally
failed to amplify each and all exons individually. Not being able to
gain information on the totality of the sequence we thus excluded
TLR3 from this study. Every PCR reaction was performed in
duplicate. One was used for direct sequencing and the other, if
necessary (when a heterozygous position was detected upon direct
sequencing of the amplicon) served to clone the fragment. Cloning
was performed using the TA cloning kitH (Invitrogen) according to
the manufacturer’s protocol. For each construction, 12 clones were
purified and sequenced, which enabled in most case the
identification of the 2 alleles from the donor. Nucleotide sequence
Figure7.Schematic representationof TLR8 and positionand frequencyof SingleNucleotide Polymorphisms(SNPs). LegendissimilartoFig.1.
doi:10.1371/journal.pone.0007803.g007
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the NCBI database under the accession numbers given in Table
S11.
SNP and allelic frequencies
SNP frequency is calculated as the occurrence of a specific
heterozygote position in relation to the total number of samples
(N) (or donors, necessarily diploid) for which a given TLR was
successfully sequenced (see text for the amount of successful PCR
for each TLR). Allelic frequency is reported to the number of
chromosomes (2N) which were sequenced.
Supporting Information
Table S1 Frequency of the TLR1 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s001 (0.01 MB
XLS)
Table S2 Frequency of the TLR2 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s002 (0.01 MB
XLS)
Table S3 Frequency of the TLR4 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s003 (0.01 MB
XLS)
Table S4 Frequency of the TLR5 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s004 (0.01 MB
XLS)
Table S5 Frequency of the TLR6 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s005 (0.01 MB
XLS)
Table S6 Frequency of the TLR7 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s006 (0.01 MB
XLS)
Table S7 Frequency of the TLR8 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s007 (0.01 MB
XLS)
Table S8 Frequency of the TLR9 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Figure 8. Schematic representation of TLR9 and position and frequency of Single Nucleotide Polymorphisms (SNPs). Legend is similar
to Fig. 1.
doi:10.1371/journal.pone.0007803.g008
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XLS)
Table S9 Frequency of the TLR10 alleles at the nucleotidic (top)
and proteic (bottom) level. Bold letters indicate Non Synonymous
Single Nucleotide Polymorphisms (NS-SNPs).
Found at: doi:10.1371/journal.pone.0007803.s009 (0.01 MB
XLS)
Table S10 Oligonucleotides and PCR conditions used for
analysis of TLR genes.
Found at: doi:10.1371/journal.pone.0007803.s010 (0.01 MB
XLS)
Table S11 Genbank accession numbers for all TLR alleles
described in this study.
Found at: doi:10.1371/journal.pone.0007803.s011 (0.01 MB
XLS)
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